Citizens Jmp Downgrades Angi Rating

Summary

Citizens Jmp recently downgraded Angi’s (NASDAQ: ANGI) rating from ‘Outperform’ to ‘Market Perform.’ Other analysts have also adjusted their ratings and target prices, with RBC lowering its target price from $27.50 to $17.00. Angi’s average rating is ‘Moderate Buy,’ with a target price of $21.36. The stock opened at $15.44, with a 12-month low of $10.88 and a high of $29.15. Angi’s reported earnings per share last quarter exceeded expectations at $0.30. Market Beat

Impact Analysis

This event is classified at the company level because it specifically concerns Angi’s stock rating and price target changes. The downgrade by Citizens Jmp and other analysts reflects shifting sentiment around Angi’s performance prospects. The first-order effects include potential negative impacts on Angi’s stock price due to the downgrade, as investors may react to the revised expectations. The second-order effects could involve changes in investment behavior, with investors possibly reassessing their positions in Angi, leading to volatility in the stock. Investment opportunities may exist for those looking to capitalize on potential price corrections or for long-term investors who believe in Angi’s business fundamentals despite recent downgrades. Risks include continued negative sentiment and further downgrades from other analysts, which could apply additional downward pressure on the stock. Market Beat+ 2